Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.
Saved in:
| Title: | Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. |
|---|---|
| Authors: | Diener HC; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Grosse GM; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany.; Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland., Hüsing A; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Stang A; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; School of Public Health, Department of Epidemiology Boston University, Boston, MA, United States of America., Kuklik N; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Brinkmann M; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; Center for Clinical Trials Essen, University Hospital Essen, Essen, Germany., Maurer GD; Department of Neurology, University Hospital Frankfurt, Goethe University Frankfurt, Germany., Soda H; Klinik für Akutneurologie mit Überregionaler Stroke Unit, Klinischer Neurophysiologie und Intensivmedizin, Rhön-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany., Pohlmann C; Department of Neurology, Asklepios Klinik Barmbek, Hamburg, Germany., Hilker-Roggendorf R; Department of Neurology, Klinikum Vest, Recklinghausen.; Ruhr-University, Bochum, Germany., Popovic N; Department of Neurology, Evangelisches Krankenhaus Hattingen, Hattingen, Germany., Kraft P; Klinikum Main-Spessart Lohr, Germany., Mackert BM; Department of Neurology, Vivantes Auguste-Viktoria Hospital, Berlin, Germany., Eschenfelder CC; Human Pharma Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Weimar C; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; BDH Clinic Elzach, Elzach, Germany. |
| Source: | European stroke journal [Eur Stroke J] 2024 Sep; Vol. 9 (3), pp. 696-703. Date of Electronic Publication: 2024 Apr 03. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: SAGE Publications Ltd Country of Publication: England NLM ID: 101688446 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2396-9881 (Electronic) Linking ISSN: 23969873 NLM ISO Abbreviation: Eur Stroke J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2396-9881 |
|---|---|
| DOI: | 10.1177/23969873241242239 |
